Literature DB >> 27650938

Quantitative Assessment of Radionuclide Uptake and Positron Emission Tomography-computed Tomography Image Contrast.

Hasford Francis1, John Humphrey Amuasi2, Kyere Augustine Kwame2, Mboyo Di Tamba Vangu3.   

Abstract

Radionuclide uptake and contrast for positron emission tomography-computed tomography (PET-CT) images have been assessed in this study using NEMA image quality phantom filled with background activity concentration of 5.3 kBq/mL fluorodeoxyglucose (F-18 FDG). Spheres in the phantom were filled in turns with water to mimic cold lesions and FDG of higher activity concentrations to mimic tumor sites. Transaxial image slices were acquired on the PET-CT system and used for the evaluation of mean standard uptake value (SUVmean) and contrasts for varying sphere sizes at different activity concentrations of 10.6 kBq/mL, 21.2 kBq/mL, and 42.4 kBq/mL. For spheres of same sizes, SUVmean increased with increase in activity concentration. SUVmean was increased by 80.6%, 83.5%, 63.2%, 87.4%, and 63.2% when activity concentrations of spheres with a diameter of 1.3 cm, 1.7 cm, 2.2 cm, 2.8 cm, and 3.7 cm, respectively, were increased from 10.6 kBq/mL to 42.4 kBq/mL. Average percentage contrast between cold spheres (cold lesions) and background activity concentration was estimated to be 89.96% for the spheres. Average contrast for the spheres containing 10.6 kBq/mL, 21.2 kBq/mL, and 42.4 kBq/mL were found to be 110.92%, 134.48%, and 150.52%, respectively. The average background contrast variability was estimated to be 2.97% at 95% confidence interval (P < 0.05).

Entities:  

Keywords:  Hot lesion; image contrast; image quality phantom; radionuclide activity

Year:  2016        PMID: 27650938      PMCID: PMC5020789          DOI: 10.4103/1450-1147.174702

Source DB:  PubMed          Journal:  World J Nucl Med        ISSN: 1450-1147


  25 in total

Review 1.  Concurrent PET/CT with an integrated imaging system: intersociety dialogue from the joint working group of the American College of Radiology, the Society of Nuclear Medicine, and the Society of Computed Body Tomography and Magnetic Resonance.

Authors:  R Edward Coleman; Dominique Delbeke; Milton J Guiberteau; Peter S Conti; Henry D Royal; Jeffrey C Weinreb; Barry A Siegel; Michael F Federle; David W Townsend; Lincoln L Berland
Journal:  J Nucl Med       Date:  2005-07       Impact factor: 10.057

Review 2.  Standards for PET image acquisition and quantitative data analysis.

Authors:  Ronald Boellaard
Journal:  J Nucl Med       Date:  2009-04-20       Impact factor: 10.057

3.  Revised response criteria for malignant lymphoma.

Authors:  Bruce D Cheson; Beate Pfistner; Malik E Juweid; Randy D Gascoyne; Lena Specht; Sandra J Horning; Bertrand Coiffier; Richard I Fisher; Anton Hagenbeek; Emanuele Zucca; Steven T Rosen; Sigrid Stroobants; T Andrew Lister; Richard T Hoppe; Martin Dreyling; Kensei Tobinai; Julie M Vose; Joseph M Connors; Massimo Federico; Volker Diehl
Journal:  J Clin Oncol       Date:  2007-01-22       Impact factor: 44.544

Review 4.  Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development.

Authors:  Gary J Kelloff; John M Hoffman; Bruce Johnson; Howard I Scher; Barry A Siegel; Edward Y Cheng; Bruce D Cheson; Joyce O'shaughnessy; Kathryn Z Guyton; David A Mankoff; Lalitha Shankar; Steven M Larson; Caroline C Sigman; Richard L Schilsky; Daniel C Sullivan
Journal:  Clin Cancer Res       Date:  2005-04-15       Impact factor: 12.531

5.  Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group.

Authors:  H Young; R Baum; U Cremerius; K Herholz; O Hoekstra; A A Lammertsma; J Pruim; P Price
Journal:  Eur J Cancer       Date:  1999-12       Impact factor: 9.162

Review 6.  Predictive and prognostic value of FDG-PET in nonsmall-cell lung cancer: a systematic review.

Authors:  Lioe-Fee de Geus-Oei; Henricus F M van der Heijden; Frans H M Corstens; Wim J G Oyen
Journal:  Cancer       Date:  2007-10-15       Impact factor: 6.860

7.  Comparison of different SUV-based methods for monitoring cytotoxic therapy with FDG PET.

Authors:  A Stahl; K Ott; M Schwaiger; W A Weber
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-07-15       Impact factor: 9.236

8.  Effects of noise, image resolution, and ROI definition on the accuracy of standard uptake values: a simulation study.

Authors:  Ronald Boellaard; Nanda C Krak; Otto S Hoekstra; Adriaan A Lammertsma
Journal:  J Nucl Med       Date:  2004-09       Impact factor: 10.057

9.  Non-invasive estimation of the net influx constant using the standardized uptake value for quantification of FDG uptake of tumours.

Authors:  N Sadato; T Tsuchida; S Nakaumra; A Waki; H Uematsu; N Takahashi; N Hayashi; Y Yonekura; Y Ishii
Journal:  Eur J Nucl Med       Date:  1998-06

10.  Optimum scanning protocol for FDG-PET evaluation of pulmonary malignancy.

Authors:  V J Lowe; D M DeLong; J M Hoffman; R E Coleman
Journal:  J Nucl Med       Date:  1995-05       Impact factor: 10.057

View more
  1 in total

1.  Accuracy Assessment of SUV Measurements in SPECT/CT: A Phantom Study.

Authors:  Fatin Halim; Hizwan Yahya; Khairul Nizam Jaafar; Syahir Mansor
Journal:  J Nucl Med Technol       Date:  2021-03-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.